Genomelink, founded in 2017, is a pioneering entity in the Biotechnology industry, headquartered in the United States. It positions itself as a "DNA App Store," facilitating the upload and storage of DNA data to provide users with extensive insights, products, and health research opportunities.
The company’s mission is threefold: to establish a leading consumer application platform, to aid the progress of genomics and health science, and to restore DNA data ownership to the individual. Such a user-centric approach could significantly disrupt traditional DNA data paradigms by emphasizing personal data sovereignty.
Genomelink last secured a $3.50M Seed Round investment on 01 July 2021, backed by notable investors including Y Combinator, Liquid 2 Ventures, Lair East Labs, SandHill Angels, R42, SAV (Scale Asia Ventures), and Newton Fund. These partnerships underscore strong confidence in their innovative model and growth potential.